Covigilant Research, LLC Clinical Trials Site Management Organization

Covigilant Research, LLC

Committed To Working Together

Phio Pharmaceuticals obtains clearance for melanoma treatment trial,

With the clinical trial authorisation (CTA), the company will start a first-in-human trial for PH-762 in melanoma patients at the Gustave Roussy …, With the clinical trial authorisation (CTA), the company will start a first-in-human trial for PH-762 in melanoma patients at the Gustave Roussy …, Read More

Scroll to Top